单位(元)圆信永丰医药健康A(006274)利润表 |
| 报告期 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
| 收入 |
108,371,228 |
89,653,923 |
-35,868,753 |
-75,116,443 |
| 利息收入 |
135,514 |
45,643 |
21,048 |
10,243 |
| 其中:存款利息收入 |
113,721 |
34,742 |
15,570 |
8,145 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
21,794 |
10,901 |
5,479 |
2,098 |
| 投资收益 |
157,322,843 |
49,092,038 |
-33,806,965 |
-19,565,717 |
| 其中:股票投资收益 |
152,787,324 |
46,349,457 |
-36,333,519 |
-21,170,554 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
268,527 |
95,697 |
956,618 |
775,169 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
4,266,992 |
2,646,884 |
1,569,936 |
829,668 |
| 公允价值变动收益 |
-50,987,313 |
39,771,650 |
-3,064,759 |
-56,005,500 |
| 汇兑收益 |
- |
- |
- |
- |
| 其他收入 |
1,900,184 |
744,592 |
981,922 |
444,531 |
| 费用 |
10,291,942 |
2,710,209 |
2,777,498 |
1,722,391 |
| 管理人报酬 |
8,307,893 |
2,187,685 |
2,237,900 |
1,378,552 |
| 托管费 |
1,384,649 |
364,614 |
372,983 |
229,759 |
| 销售服务费 |
404,282 |
75,776 |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
22,082 |
10,450 |
22,393 |
15,724 |
| 其中:卖出回购金融资产支出 |
22,082 |
10,450 |
22,393 |
15,724 |
| 其他费用 |
172,919 |
71,684 |
144,208 |
98,343 |
| 利润总额 |
98,079,286 |
86,943,714 |
-38,646,251 |
-76,838,834 |
| 减:所得税费用 |
- |
- |
- |
- |
| 净利润 |
98,079,286 |
86,943,714 |
-38,646,251 |
-76,838,834 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。